Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Feb 27, 2022; 14(2): 143-160
Published online Feb 27, 2022. doi: 10.4240/wjgs.v14.i2.143
Published online Feb 27, 2022. doi: 10.4240/wjgs.v14.i2.143
Table 2 Univariate and multivariate analyses of clinicopathological factors of patients with pT1N2-3b GC
Characteristic | pT1N2-3b | |||
Univariate analysis | Multivariate analysis | |||
HR (95%CI) | P value | HR (95%CI) | P value | |
Sex | 0.870 | - | - | |
Male | 1.000 | |||
Female | 0.929 (0.387-2.233) | |||
Age (yr) | 1.044 (1.001-1.089) | 0.044 | 1.022 (0.978-1.069) | 0.335 |
BMI (kg/m2) | 0.924 (0.815-1.047) | 0.216 | - | - |
Neutrophils (109/L) | 1.034 (0.795-1.345) | 0.802 | - | - |
Lymphocytes (109/L) | 0.616 (0.297-1.278) | 0.193 | - | - |
Platelets (109/L) | 0.999 (0.992-1.006) | 0.692 | - | - |
Fibrinogen (g/L) | 1.277 (0.723-2.256) | 0.399 | - | - |
ALT (U/L) | 1.000 (0.973-1.029) | 0.972 | - | - |
AST (U/L) | 1.016 (0.968-1.067) | 0.521 | - | - |
Albumin (g/L) | 0.926 (0.833-1.028) | 0.150 | - | - |
Prealbumin (mg/L) | 0.986 (0.977-0.995) | 0.003 | 0.990 (0.981-1.000) | 0.040 |
CEA (ng/mL) | 1.254 (1.074-1.464) | 0.004 | 1.199 (1.028-1.399) | 0.021 |
CA19-9 (U/mL) | 1.000 (0.972-1.028) | 0.992 | - | - |
Tumor diameter (mm) | 0.986 (0.961-1.013) | 0.307 | - | - |
Gastrectomy | 0.683 | - | - | |
Partial gastrectomy | 1.000 | |||
Total gastrectomy | 1.356 (0.314-5.851) | |||
Histological type | 0.324 | - | - | |
Differentiated | 1.000 | |||
Undifferentiated | 1.665 (0.605-4.581) | |||
pN stage | 0.251 | - | - | |
N2 | 1.000 | |||
N3 | 1.752 (0.673-4.562) | |||
mLNR | 47.797 (5.421-421.417) | < 0.001 | 17.488 (1.215-251.748) | 0.035 |
Vascular infiltration | 0.187 | - | - | |
No | 1.000 | |||
Yes | 1.865 (0.738-4.708) | |||
Nerve infiltration | 0.989 | - | - | |
No | 1.000 | |||
Yes | 1.010 (0.234-4.359) | |||
Postoperative chemotherapy | 0.528 | - | - | |
Yes | 1.000 | |||
No | 0.744 (0.297-1.865) |
- Citation: Wang YF, Yin X, Fang TY, Wang YM, Zhang DX, Zhang Y, Wang XB, Wang H, Xue YW. Nomograms predicting prognosis of patients with pathological stages T1N2-3 and T3N0 gastric cancer. World J Gastrointest Surg 2022; 14(2): 143-160
- URL: https://www.wjgnet.com/1948-9366/full/v14/i2/143.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i2.143